In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates

about

Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm Daptomycin - a novel antibiotic against Gram-positive pathogens.

P2860

Q34228237-E1068D1E-3838-499C-934E-2C19D8AFD2FA Q35925535-43D225D3-8C46-43DC-B18A-21A91E9F5B07

P2860

In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates

Item

http://www.wikidata.org/entity/Q35685332

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

In vitro activities of a new l ...... sistant gram-positive isolates

@ast

In vitro activities of a new l ...... sistant gram-positive isolates

@en

type

Item

label

In vitro activities of a new l ...... sistant gram-positive isolates

@ast

In vitro activities of a new l ...... sistant gram-positive isolates

@en

prefLabel

In vitro activities of a new l ...... sistant gram-positive isolates

@ast

In vitro activities of a new l ...... sistant gram-positive isolates

@en

P1476

In vitro activities of a new l ...... sistant gram-positive isolates

@en

P2093

Andre Bryskier

http://www.w3.org/2001/XMLSchema#string

Henri Drugeon

http://www.w3.org/2001/XMLSchema#string

Marie-Emmanuelle Juvin

http://www.w3.org/2001/XMLSchema#string

Pascale Bemer

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.

Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens

In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers

Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations.

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.

In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.

Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.

Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.

In vitro activity of LY146032 (daptomycin), a new peptolide.

P304

3025-3029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.47.9.3025-3029.2003

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12937020

http://www.w3.org/2001/XMLSchema#string

P921

Gram-positive bacteria

P932

182620

http://www.w3.org/2001/XMLSchema#string

In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates

about

P2860

P2860

In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932